from 14/53 of the Preliminary Final Report released 28/08 -
'The management has been able to introduce Intelliheart into the retail environment having secured an exclusive ditribution arrangement with Sigma's national chain of pharmacies. This will greatly enhance the company's future income stream as well as ensuring that Australians have ready access to the benefits that the Intelliheart test provides.'
Does this need further announcement to the market or is it now just common knowledge
IMI Price at posting:
0.0¢ Sentiment: Buy Disclosure: Held
